Allogeneic CAR T-cell therapy(Factor Bioscience)

N/A

Report date: 2025/02/13 14:24:01

Base Information

Drug NameAllogeneic CAR T-cell therapy(Factor Bioscience)
Drug Alias Name同种异体CAR-T细胞疗法（Factor Bioscience）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFactor Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesFactor Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A